804 related articles for article (PubMed ID: 17918267)
1. FTY720 modulates human oligodendrocyte progenitor process extension and survival.
Miron VE; Jung CG; Kim HJ; Kennedy TE; Soliven B; Antel JP
Ann Neurol; 2008 Jan; 63(1):61-71. PubMed ID: 17918267
[TBL] [Abstract][Full Text] [Related]
2. Sphingosine-1-phosphate stimulates the functional capacity of progenitor cells by activation of the CXCR4-dependent signaling pathway via the S1P3 receptor.
Walter DH; Rochwalsky U; Reinhold J; Seeger F; Aicher A; Urbich C; Spyridopoulos I; Chun J; Brinkmann V; Keul P; Levkau B; Zeiher AM; Dimmeler S; Haendeler J
Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):275-82. PubMed ID: 17158356
[TBL] [Abstract][Full Text] [Related]
3. The immunomodulator FTY720 has a direct cytoprotective effect in oligodendrocyte progenitors.
Coelho RP; Payne SG; Bittman R; Spiegel S; Sato-Bigbee C
J Pharmacol Exp Ther; 2007 Nov; 323(2):626-35. PubMed ID: 17726159
[TBL] [Abstract][Full Text] [Related]
4. Role of p38MAPK in S1P receptor-mediated differentiation of human oligodendrocyte progenitors.
Cui QL; Fang J; Kennedy TE; Almazan G; Antel JP
Glia; 2014 Aug; 62(8):1361-75. PubMed ID: 24810969
[TBL] [Abstract][Full Text] [Related]
5. Neurological S1P signaling as an emerging mechanism of action of oral FTY720 (fingolimod) in multiple sclerosis.
Lee CW; Choi JW; Chun J
Arch Pharm Res; 2010 Oct; 33(10):1567-74. PubMed ID: 21052934
[TBL] [Abstract][Full Text] [Related]
6. FTY720 inhibits S1P-mediated endothelial healing: relationship to S1P1-receptor surface expression.
Krump-Konvalinkova V; Chwalla I; Siess W
Biochem Biophys Res Commun; 2008 Jun; 370(4):603-8. PubMed ID: 18402775
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of cell motility observed with high doses of sphingosine 1-phosphate or phosphorylated FTY720 involves RGS2 through its interactions with the receptor S1P.
Kohno T; Igarashi Y
Genes Cells; 2008 Jul; 13(7):747-57. PubMed ID: 18513330
[TBL] [Abstract][Full Text] [Related]
8. Cyclical and dose-dependent responses of adult human mature oligodendrocytes to fingolimod.
Miron VE; Hall JA; Kennedy TE; Soliven B; Antel JP
Am J Pathol; 2008 Oct; 173(4):1143-52. PubMed ID: 18772343
[TBL] [Abstract][Full Text] [Related]
9. Activation of sphingosine-1-phosphate receptor S1P5 inhibits oligodendrocyte progenitor migration.
Novgorodov AS; El-Alwani M; Bielawski J; Obeid LM; Gudz TI
FASEB J; 2007 May; 21(7):1503-14. PubMed ID: 17255471
[TBL] [Abstract][Full Text] [Related]
10. Sphingosine 1-phosphate receptor expression profile in human gastric cancer cells: differential regulation on the migration and proliferation.
Yamashita H; Kitayama J; Shida D; Yamaguchi H; Mori K; Osada M; Aoki S; Yatomi Y; Takuwa Y; Nagawa H
J Surg Res; 2006 Jan; 130(1):80-7. PubMed ID: 16183075
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of 4(5)-phenylimidazole-based analogues of sphingosine-1-phosphate and FTY720: discovery of potent S1P1 receptor agonists.
Clemens JJ; Davis MD; Lynch KR; Macdonald TL
Bioorg Med Chem Lett; 2005 Aug; 15(15):3568-72. PubMed ID: 15982878
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylated FTY720 stimulates ERK phosphorylation in astrocytes via S1P receptors.
Osinde M; Mullershausen F; Dev KK
Neuropharmacology; 2007 Apr; 52(5):1210-8. PubMed ID: 17379261
[TBL] [Abstract][Full Text] [Related]
13. Role of sphingosine 1-phosphate receptor type 1 in lymphocyte egress from secondary lymphoid tissues and thymus.
Chiba K; Matsuyuki H; Maeda Y; Sugahara K
Cell Mol Immunol; 2006 Feb; 3(1):11-9. PubMed ID: 16549044
[TBL] [Abstract][Full Text] [Related]
14. Sphingosine-1-phosphate is released by cerebellar astrocytes in response to bFGF and induces astrocyte proliferation through Gi-protein-coupled receptors.
Bassi R; Anelli V; Giussani P; Tettamanti G; Viani P; Riboni L
Glia; 2006 Apr; 53(6):621-30. PubMed ID: 16470810
[TBL] [Abstract][Full Text] [Related]
15. The G protein-coupled receptor S1P2 regulates Rho/Rho kinase pathway to inhibit tumor cell migration.
Lepley D; Paik JH; Hla T; Ferrer F
Cancer Res; 2005 May; 65(9):3788-95. PubMed ID: 15867375
[TBL] [Abstract][Full Text] [Related]
16. Sphingosine 1-phosphate mediates proliferation and survival of mesoangioblasts.
Donati C; Cencetti F; Nincheri P; Bernacchioni C; Brunelli S; Clementi E; Cossu G; Bruni P
Stem Cells; 2007 Jul; 25(7):1713-9. PubMed ID: 17464089
[TBL] [Abstract][Full Text] [Related]
17. Sphingosine 1-phosphate receptors in health and disease: mechanistic insights from gene deletion studies and reverse pharmacology.
Brinkmann V
Pharmacol Ther; 2007 Jul; 115(1):84-105. PubMed ID: 17561264
[TBL] [Abstract][Full Text] [Related]
18. Interactions between sphingosine-1-phosphate and vascular endothelial growth factor signalling in ML-1 follicular thyroid carcinoma cells.
Balthasar S; Bergelin N; Löf C; Vainio M; Andersson S; Törnquist K
Endocr Relat Cancer; 2008 Jun; 15(2):521-34. PubMed ID: 18509004
[TBL] [Abstract][Full Text] [Related]
19. Central nervous system-directed effects of FTY720 (fingolimod).
Miron VE; Schubart A; Antel JP
J Neurol Sci; 2008 Nov; 274(1-2):13-7. PubMed ID: 18678377
[TBL] [Abstract][Full Text] [Related]
20. The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G-protein-coupled receptors.
Gräler MH; Goetzl EJ
FASEB J; 2004 Mar; 18(3):551-3. PubMed ID: 14715694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
